SGN-CD352A: A novel humanized anti-CD352 antibody -drug conjugate for the treatment of multiple myeloma

被引：10
|
作者：
Lewis, Tim
Olson, Devra J.
Gordon, Kristine A.
Sandal, Sharsti L.
Miyamoto, Jamie
VVestendorf, Lori
Linares, Germein
Leiske, Chris
Kostner, Heather
Stone, Ivan
Anderson, Martha
Nesterova, Albina
Jonas, Mechthild
Law, Che-Leung
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-1195
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1195
引用
收藏
页数：3
相关论文
共 50 条
  • [31] A novel anti-CD37 antibody-drug conjugate with multiple anti-tumor mechanisms for the treatment of B-cell malignancies
    Deckert, Jutta
    Park, Peter U.
    Chicklas, Sharon
    Yi, Yong
    Li, Min
    Lai, Katharine C.
    Mayo, Michele F.
    Carrigan, Christina N.
    Erickson, Hans K.
    Pinkas, Jan
    Lutz, Robert J.
    Chittenden, Thomas
    Lambert, John M.
    BLOOD, 2013, 122 (20) : 3500 - 3510
  • [32] SGN-70, a humanized Anti-CD70 antibody, targets CD70-Expressing hematologic tumors.
    McEarchern, Julie A.
    McDonagh, Charlotte F.
    Smith, Leia M.
    Klussman, Kerry
    Oflazoglu, Ezogelin
    Morris-Tilden, Carol
    Stone, Ivan
    McCormick, Renee
    Carter, Paul
    Gerber, Hanspeter
    Grewal, Iqbal S.
    Law, Che-Leung
    BLOOD, 2006, 108 (11) : 706A - 706A
  • [33] An anti-CD38 antibody drug conjugate for the treatment of diverse hematologic malignancies
    Prudent, James R.
    Marshall, David J.
    Murphy, John
    Malavasi, Fabio
    CANCER RESEARCH, 2015, 75
  • [34] First Trial of Humanized Anti-CD74 Monoclonal Antibody (MAb), Milatuzumab, in Multiple Myeloma.
    Kaufman, Jonathan
    Niesvizky, Ruben
    Stadtmauer, Edward A.
    Chanan-Khan, Asher
    Siegel, David
    Home, Heather
    Teoh, Nick
    Leoni, Matthew J.
    Wegener, William A.
    Goldenberg, David M.
    BLOOD, 2008, 112 (11) : 1266 - 1267
  • [35] Dose-escalation trial of milatuzumab (humanized anti-CD74 monoclonal antibody) in multiple myeloma
    Kaufman, J. L.
    Niesvizky, R.
    Stadtmauer, E. A.
    Chanan-Khan, A.
    Siegel, D.
    Horne, H.
    Teoh, N.
    Wegener, W. A.
    Goldenberg, D. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [36] The Anti-CD38 Antibody Therapy in Multiple Myeloma
    Petrucci, Maria Teresa
    Vozella, Federico
    CELLS, 2019, 8 (12)
  • [37] Pharmacokinetic-Pharmacodynamic Modeling of the Antitumor Effects of SGN-CD19A, a Novel Antibody-Drug Conjugate, in Mice
    Zhao, Baiteng
    Stevison, Faith
    Law, Che-Leung
    Han, Tae H.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2013, 40 : S17 - S18
  • [38] SGN-CD33A: a novel CD33-targeting antibody-drug conjugate using a pyrrolobenzodiazepine dimer is active in models of drug-resistant AML
    Sutherland, May S. Kung
    Walter, Roland B.
    Jeffrey, Scott C.
    Burke, Patrick J.
    Yu, Changpu
    Kostner, Heather
    Stone, Ivan
    Ryan, Maureen C.
    Sussman, Django
    Lyon, Robert P.
    Zeng, Weiping
    Harrington, Kimberly H.
    Klussman, Kerry
    Westendorf, Lori
    Meyer, David
    Bernstein, Irwin D.
    Senter, Peter D.
    Benjamin, Dennis R.
    Drachman, Jonathan G.
    McEarchern, Julie A.
    BLOOD, 2013, 122 (08) : 1455 - 1463
  • [39] Preclinical investigation of SGN-CD70A antibody-drug conjugate in T cell lymphomas
    Yang, Chen-Yen
    Wang, Linlin
    Pincus, Laura
    McCormick, Frank
    Gill, Ryan
    Ai, Wei
    CANCER RESEARCH, 2017, 77
  • [40] A novel CD30-directed antibody-drug conjugate for the treatment of lymphomas
    Hamblett, Kevin J.
    Jin, Steven
    Yumul, Roma
    Chen, Yufei
    Kwon, John
    Simmons, Jessica
    Henderson, Clark
    Sun, Hao
    Schrum, Jason P.
    Lim, Andrea R.
    Bindman, Noah A.
    Canerly, Melissa
    Clarke, Astrid
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
12345